These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Chemical agents for treatment of and emergency protection against smallpox]. Ladnyĭ ID; Ogorodnikova ZI; Davydov SU Vopr Virusol; 1976; (1):4-12. PubMed ID: 1258454 [No Abstract] [Full Text] [Related]
25. [Study of the antiviral activity of marborane and its analogs in experimental smallpox in rabbits]. Loziuk LV Mikrobiol Zh; 1974; 36(2):224-9. PubMed ID: 4465655 [No Abstract] [Full Text] [Related]
26. Complications of smallpox vaccination, 1968. Lane JM; Ruben FL; Neff JM; Millar JD N Engl J Med; 1969 Nov; 281(22):1201-8. PubMed ID: 4186802 [No Abstract] [Full Text] [Related]
27. Variola minor in the United States. Wolman IJ Clin Pediatr (Phila); 1967 Sep; 6(9):514. PubMed ID: 6047884 [No Abstract] [Full Text] [Related]
28. Chemoprophylaxis of smallpox and treatment of vaccinia gangrenosa with 1-methylisatin 3-thiosemicarbazone. Bauer DJ Antimicrob Agents Chemother (Bethesda); 1965; 5():544-7. PubMed ID: 5883471 [No Abstract] [Full Text] [Related]
29. [Treatment of virus diseases]. Vivell O Med Klin; 1970 Oct; 65(42):1812-5. PubMed ID: 4103874 [No Abstract] [Full Text] [Related]
30. PROPHYLACTIC TREATMENT OF SMALL POX CONTACTS WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN). BAUER DJ; STVINCENT L; KEMPE CH; DOWNIE AW Lancet; 1963 Sep; 2(7306):494-6. PubMed ID: 14065422 [No Abstract] [Full Text] [Related]
31. Clinical assessment of an isothizole thiosemicarbazone against smallpox. Sharma R J Indian Med Assoc; 1968 Dec; 51(12):610-2. PubMed ID: 5729412 [No Abstract] [Full Text] [Related]
32. Antiviral drugs in human therapy. Inglot AD Acta Microbiol Pol A; 1973; 5(3):183-95. PubMed ID: 4358718 [No Abstract] [Full Text] [Related]
33. [Experience with the use of cuminal-thiosemicarbazone (cutisone) for the prevention of influenza in the child population during the epidemic of 1967]. Orlova NN; Aksenova VA; Selidovkin DA; Bogdanova NS; Pershin GN Farmakol Toksikol; 1968; 31(6):725-8. PubMed ID: 4890303 [No Abstract] [Full Text] [Related]
34. Smallpox: the old and the new. Griffiths PD Rev Med Virol; 2004; 14(5):273-4. PubMed ID: 15334535 [No Abstract] [Full Text] [Related]
35. [Basis of the effect of hyperimmunoglobin, vaccine antigen and Marboran on vaccine virus infection]. Spiess H; Käckell MY; Schneweis KE Monatsschr Kinderheilkd (1902); 1966 Apr; 114(4):168-9. PubMed ID: 4168467 [No Abstract] [Full Text] [Related]
36. The future of antiviral chemotherapy. Lond Clin Med J; 1970 Jul; 11(2):10-2. PubMed ID: 5483451 [No Abstract] [Full Text] [Related]
37. Strengthening national preparedness for smallpox: an update. LeDuc JW; Jahrling PB Emerg Infect Dis; 2001; 7(1):155-7. PubMed ID: 11266310 [No Abstract] [Full Text] [Related]
38. Eczema vaccinatum. Report of four cases by contact-infection. Treatment with methiasazone (Marboran). Grosfeld JC; van Ramshorst AG Dermatologica; 1970; 141(1):1-10. PubMed ID: 4097199 [No Abstract] [Full Text] [Related]
39. SOME OBSERVATIONS ON THE ROLE OF METHISAZONE ('MARBORAN') IN THE PROPHYLAXIS OF SMALLPOX IN A RURAL AREA. FERGUSON DL S Afr Med J; 1964 Oct; 38():868-9. PubMed ID: 14212650 [No Abstract] [Full Text] [Related]
40. [Epidemiological control of smallpox virus in Ecudor]. Gutierrez Vera E Rev Ecuat Hig Med Trop; 1976; 29():13-24. PubMed ID: 189361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]